Pain Management

With Passion against Pain

As an independent, global pharmaceutical company with long-time experience in the development of innovative analgesics, Grünenthal is passionate about striving towards being a preferred partner in pain.

The European Federation of the International Association of the Study of Pain chapters (EFIC®) states that, whereas acute pain may reasonably be considered a symptom of disease or injury, chronic and recurrent pain is a specific healthcare problem, a disease in its own right. Pain and especially chronic pain can have a significant negative impact on the quality of life for patients and their loved ones.

Pain lasting weeks, months or even years considerably reduces quality of life and can impact patients socially, physically and psychologically. In these patients, our goal is to control the pain with the minimum of side effects.